Status: current, Defined. Date: 31-Oct 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1693731000168116 | aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 20 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1693741000168113 | aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 20 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 20 | Is a | aspirin 300 mg tablet, 20 | true | Inferred relationship | Some | ||
| aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 20 | has MPUU | aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Aspalgin dispersible tablet, 20 | Is a | True | aspirin 300 mg + codeine phosphate hemihydrate 8 mg dispersible tablet, 20 | Inferred relationship | Some |
Reference Sets
Tasmania reportable Schedule 4 medications reference set
Victoria reportable Schedule 4 medications reference set
South Australia reportable Schedule 4 medications reference set
Queensland Health QScript Schedule 4 monitored medicines reference set
New South Wales Reportable Schedule 4 medications reference set
Northern Territory Reportable Schedule 4 medications reference set
ACT Reportable Schedule 4 medications reference set
Western Australia Health Schedule 4 restricted medicines for public hospitals reference set
Medicinal product pack reference set
FHIR